Ipamorelin
Ipamorelin Research: A Pentapeptide Growth-Hormone Secretagogue
Ipamorelin is a pentapeptide secretagogue studied in ghrelin-receptor and growth-hormone-axis research.
What Ipamorelin is
Ipamorelin is a pentapeptide, meaning it contains five amino-acid residues. It is commonly classified as a growth-hormone secretagogue peptide in research literature.
Secretagogues are compounds that stimulate secretion pathways. Ipamorelin is discussed in relation to the ghrelin receptor, also known as the growth-hormone secretagogue receptor or GHSR-1a.
Research-use only: the material is supplied for laboratory research, not for human or veterinary administration.
Receptor selectivity
Ipamorelin is often compared with other secretagogues because receptor selectivity changes how compounds are characterized in experimental systems.
Peptide sequence, molecular shape and receptor affinity influence how a compound behaves in binding assays and preclinical signaling models. Ipamorelin's pentapeptide structure is part of its distinct research identity.
Relation to CJC-1295 no DAC
Ipamorelin and CJC-1295 no DAC both relate to the growth-hormone axis, but the receptor mechanisms differ. Ipamorelin is a secretagogue peptide, while CJC-1295 no DAC is a GHRH analog.
The two-compound pairing is therefore a receptor-pathway pairing rather than a single shared mechanism.
Research-use boundary
Unauthorized human-use risk context
This section is a safety boundary, not application guidance. The material is not supplied for human or veterinary administration, and the points below do not describe expected effects or acceptable use.
- Research-use material has not been supplied as a finished pharmaceutical product, so unauthorized human use can involve unknown identity, impurity, sterility, immune-response and contamination risks.
- Because this compound is discussed around endocrine-axis signaling, unauthorized human use could theoretically disturb hormone-related feedback systems, fluid balance, glucose handling, sleep, appetite or other regulated processes.
- Because Ipamorelin is discussed around ghrelin-receptor signaling, unauthorized human exposure could theoretically affect appetite, metabolic signaling or endocrine feedback in ways not characterized for this material.
- If a non-sterile or improperly characterized material were introduced into the body, possible risks include infection, inflammatory reactions, fever-like responses, local tissue irritation and other serious adverse events.
